Dare Bioscience offers women’s reproductive health devices, therapeutics and diagnostics and provides contraception, vaginal health, pain and fertility products. Two products in clinical development include Ovaprene, a non-hormonal monthly contraceptive ring and SST-6007 (5% Topical Sildenafil Citrate Cream), containing the same active ingredient in Viagra in a proprietary cram formulation for treating Female Sexual Arousal Disorder.
Dare Bioscience acquired Cerulean Pharma, a nanotechnology-based therapeutics company in 2017. In 2018 Dare Bioscience entered a merger with Pear Tree Pharmaceuticals that includes securing rights to PT-101, a vaginal formulation of tamoxifen as a treatment for vulvar and vaginal atrophy in hormone-receptor-positive breast cancer patients.
Documentaries, videos and podcasts